Mingyao Ying

Hugo W. Moser Res Inst Kennedy Krieger

$2,657,206

Attributed

$2,657,206

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $838.7K · FY2017–21

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$2,657,206 · 3

By mechanism

R01$1,767,715 · 1

R21$889,491 · 2

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Clinically Translatable”

Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
Lynn Briscoe · Leidos Biomedical Research, Inc.$130,241,827
Leonard Freedmand · Leidos Biomedical Research, Inc.$95,252,769
Bambra Strokes · Ppd Development Lp$65,000,267
Klaus Romero · Critical Path Institute$56,862,776
Prasant Mohapatra · University Of California At Davis$51,504,377

Research focus

Clinically TranslatableFda ApprovedTumorigenicityInsightNeoplastic CellCellsSolidTumorXenograft ProcedureMolecularSignal TransductionGenetic TranscriptionPharmaceutical PreparationsPre-ClinicalFoundationsOncogenicBaseSignal PathwayDrug TargetingParacrinePathway InteractionsMalignant NeoplasmsMediatingFeedback